Cargando…

475 Telavancin (TLV) In vitro Activity Tested Against a USA Collection of Methicillin-resistant Staphylococcus aureus (MRSA), Including a Multidrug-resistant (MDR) Subset (2011-2013)

Detalles Bibliográficos
Autores principales: Mendes, Rodrigo E., Sader, Helio S., Flamm, Robert K., Farrell, David J., Jones, Ronald N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781562/
http://dx.doi.org/10.1093/ofid/ofu052.341
_version_ 1783294985148301312
author Mendes, Rodrigo E.
Sader, Helio S.
Flamm, Robert K.
Farrell, David J.
Jones, Ronald N.
author_facet Mendes, Rodrigo E.
Sader, Helio S.
Flamm, Robert K.
Farrell, David J.
Jones, Ronald N.
author_sort Mendes, Rodrigo E.
collection PubMed
description
format Online
Article
Text
id pubmed-5781562
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-57815622018-03-01 475 Telavancin (TLV) In vitro Activity Tested Against a USA Collection of Methicillin-resistant Staphylococcus aureus (MRSA), Including a Multidrug-resistant (MDR) Subset (2011-2013) Mendes, Rodrigo E. Sader, Helio S. Flamm, Robert K. Farrell, David J. Jones, Ronald N. Open Forum Infect Dis IDWeek 2014 Abstracts Oxford University Press 2014-12 2014-12 /pmc/articles/PMC5781562/ http://dx.doi.org/10.1093/ofid/ofu052.341 Text en © The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America
spellingShingle IDWeek 2014 Abstracts
Mendes, Rodrigo E.
Sader, Helio S.
Flamm, Robert K.
Farrell, David J.
Jones, Ronald N.
475 Telavancin (TLV) In vitro Activity Tested Against a USA Collection of Methicillin-resistant Staphylococcus aureus (MRSA), Including a Multidrug-resistant (MDR) Subset (2011-2013)
title 475 Telavancin (TLV) In vitro Activity Tested Against a USA Collection of Methicillin-resistant Staphylococcus aureus (MRSA), Including a Multidrug-resistant (MDR) Subset (2011-2013)
title_full 475 Telavancin (TLV) In vitro Activity Tested Against a USA Collection of Methicillin-resistant Staphylococcus aureus (MRSA), Including a Multidrug-resistant (MDR) Subset (2011-2013)
title_fullStr 475 Telavancin (TLV) In vitro Activity Tested Against a USA Collection of Methicillin-resistant Staphylococcus aureus (MRSA), Including a Multidrug-resistant (MDR) Subset (2011-2013)
title_full_unstemmed 475 Telavancin (TLV) In vitro Activity Tested Against a USA Collection of Methicillin-resistant Staphylococcus aureus (MRSA), Including a Multidrug-resistant (MDR) Subset (2011-2013)
title_short 475 Telavancin (TLV) In vitro Activity Tested Against a USA Collection of Methicillin-resistant Staphylococcus aureus (MRSA), Including a Multidrug-resistant (MDR) Subset (2011-2013)
title_sort 475 telavancin (tlv) in vitro activity tested against a usa collection of methicillin-resistant staphylococcus aureus (mrsa), including a multidrug-resistant (mdr) subset (2011-2013)
topic IDWeek 2014 Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781562/
http://dx.doi.org/10.1093/ofid/ofu052.341
work_keys_str_mv AT mendesrodrigoe 475telavancintlvinvitroactivitytestedagainstausacollectionofmethicillinresistantstaphylococcusaureusmrsaincludingamultidrugresistantmdrsubset20112013
AT saderhelios 475telavancintlvinvitroactivitytestedagainstausacollectionofmethicillinresistantstaphylococcusaureusmrsaincludingamultidrugresistantmdrsubset20112013
AT flammrobertk 475telavancintlvinvitroactivitytestedagainstausacollectionofmethicillinresistantstaphylococcusaureusmrsaincludingamultidrugresistantmdrsubset20112013
AT farrelldavidj 475telavancintlvinvitroactivitytestedagainstausacollectionofmethicillinresistantstaphylococcusaureusmrsaincludingamultidrugresistantmdrsubset20112013
AT jonesronaldn 475telavancintlvinvitroactivitytestedagainstausacollectionofmethicillinresistantstaphylococcusaureusmrsaincludingamultidrugresistantmdrsubset20112013